The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Recent advances in enhanced chemodynamic therapy strategies
Abstract
Abstract Chemodynamic therapy (CDT) is a novel therapeutic modality that employs Fenton or Fenton-like reactions to destroy cancer cells via the disproportionation of intratumoral hydrogen peroxide (H2O2) to the highly toxic hydroxyl radical (•OH) without external energy input. However, the poor effectiveness of CDT has limited its clinical application. Therefore, over the past few years, various strategies have been explored to enhance the efficiency of CDT. In this review, we have provided an overview of the strategies used to improve CDT performance, including the increased production, accelerated generation, and enhanced efficacy of hydroxyl radicals. Furthermore, the challenges and perspectives of emerging and potential CDT techniques are also discussed; this review is expected to stimulate the development of non-invasive and efficacious CDT techniques.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bray, F., Ferlay, J., Soerjomataram, I., Siegel, R. L., Torre, L. A., & Jemal, A. (2018) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21492 · Cited by 84,109
Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach?
Trachootham, D., Alexandre, J., & Huang, P. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2803 · Cited by 5,452
Association of reactive oxygen species levels and radioresistance in cancer stem cells
Diehn, M., Cho, R. W., Lobo, N. A., Kalisky, T., Dorie, M. J., Kulp, A. N., Qian, D., Lam, J. S., Ailles, L. E., Wong, M., et al. (2009) · Nature · doi:10.1038/nature07733 · Cited by 2,555
Endogenous Hydrogen Sulfide-Triggered MOF-Based Nanoenzyme for Synergic Cancer Therapy
Li, Y., Zhou, J., Wang, L., & Xie, Z. (2020) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.0c08659 · Cited by 125
A pH-activated autocatalytic nanoreactor for self-boosting Fenton-like chemodynamic therapy
Wu, H., Chen, F., Gu, D., You, C., & Sun, B. (2020) · Nanoscale · doi:10.1039/d0nr03135f · Cited by 79
Cited by
Zhou, Y., Fan, S., Feng, L., Huang, X., & Chen, X. (2021) · Advanced Materials · doi:10.1002/adma.202104223 · Cited by 463
Self-citationLayered double hydroxide-based nanomaterials for biomedical applications
Hu, T., Gu, Z., Williams, G. R., Strimaite, M., Zha, J., Zhou, Z., Zhang, X., Tan, C., & Liang, R. (2022) · Chemical Society Reviews · doi:10.1039/d2cs00236a · Cited by 440
Recent advances of cancer chemodynamic therapy based on Fenton/Fenton-like chemistry
Cao, C., Wang, X., Yang, N., Song, X., & Dong, X. (2022) · Chemical Science · doi:10.1039/d1sc05482a · Cited by 298
Strategies for enhancing cancer chemodynamic therapy performance
Jana, D., & Zhao, Y. (2022) · Exploration · doi:10.1002/exp.20210238 · Cited by 284
Beygi, M., Oroojalian, F., Hosseini, S. S., Mokhtarzadeh, A., Kesharwani, P., & Sahebkar, A. (2023) · Progress in Materials Science · doi:10.1016/j.pmatsci.2023.101209 · Cited by 32
Retracted
Metadata
- Authors
- Tian, Q., Xue, F., Wang, Y., Cheng, Y., An, L., Yang, S., Chen, X., & Huang, G.
- Venue
- Nano Today
- Publisher
- Elsevier BV
- Published
- 2021-08
- Volume
- 39
- Pages
- 101162
- ISSN
- 1748-0132 (ISSN-L)
- OpenAlex
- W3161723460
- Cited by
- 290
- References
- 5
- FWCI
- 15.05
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Recent advances in enhanced chemodynamic therapy strategies. https://app.cochat.ai/papers/10.1016/j.nantod.2021.101162
- The paper
- Tian, Q., Xue, F., Wang, Y., Cheng, Y., An, L., Yang, S., Chen, X., & Huang, G. (2021). Recent advances in enhanced chemodynamic therapy strategies. Nano Today. https://doi.org/10.1016/j.nantod.2021.101162
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.